Effect of OC000459 on Moderate to Severe Atopic Dermatitis

NCT02002208 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
142
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Atopix Therapeutics, Ltd.